Journal of Cancer Science and Clinical Oncology

Dr. Huafeng Zhang is a professor in School of Life Science, University of Science and Technology of China (USTC) and a selected member in CAS Hundred Talents Program. She earned her Ph. D from University of Tokyo in Japan in 2004. She went on for her postdoctoral study in National Cancer Institute of NIH from 2004 to 2005, studying protein dynamics. From 2005 to 2010, she worked in the laboratory of Dr. Gregg Semenza in Johns Hopkins University to study hypoxia and cancer development. Her major achievements include multiple highly-cited papers in the field of cancer research. In 2008, Dr. Zhang won the traditional Annual Albert Lehninger Award from Johns Hopkins University School of Medicine. She has been a professor in School of Life Science in USTC since 2011.

The major research interest of Dr. Huafeng Zhang is to decipher molecular basis underlying hypoxia and HIF (Hypoxic-inducible-factor) -mediated tumorigenesis and tumor development. Apart from mechanistic studies, screening for HIF1-specific inhibitors for cancer therapy is also under way in her lab.